Company intelligence / Profile preview

Allchemy

United States

Ownership: Private
Development stage: Commercial

Overview

Allchemy offers an advanced AI-driven software platform for drug discovery, enabling rapid design and evaluation of synthesizable small molecules with user-defined properties. The technology has been validated in scientific publications and adopted by academic, corporate, and government users worldwide. It does not itself develop clinical candidates but empowers others to do so efficiently.

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

SciY

Beyond the preview

Go deeper on Allchemy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allchemy.

Explore the full profile